Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders
US6274615A · kind A · utility
17Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 25, 1999 |
| Grant date | Aug 14, 2001 |
| Priority date | — |
| Expiry date | Mar 25, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4045
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of using melatonin to reduce, inhibit or reverse the formation of amyloid fibrils and amyloid or amyloid-like deposits. The present invention also relates to a method for delaying the onset of Alzheimer's Disease or other amyloidosis-related diseases/disorders or for treating such diseases/disorders by administering an effective amount of melatonin to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.